Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.32 USD | -0.63% | +5.16% | +277.82% |
Apr. 15 | Goldman Sachs Adjusts GeneDx Holdings Price Target to $11 From $6, Maintains Neutral Rating | MT |
Feb. 21 | Health Care Down on a Mixed Growth View -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+277.82% | 271M | |
-16.30% | 8.18B | |
+37.04% | 3.51B | |
-28.32% | 2.9B | |
-7.53% | 2.47B | |
-12.74% | 2.25B | |
-17.06% | 1.71B | |
-18.51% | 1.47B | |
-39.86% | 1.22B | |
-13.80% | 1.09B |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- Sema4 Agrees to Acquire OPKO Health Subsidiary GeneDx for $623 Million